Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H24FN5O6 |
| Molecular Weight | 461.4436 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(F)=C(C=C2)N3CCN(CC4=CC=C(O4)[N+]([O-])=O)CC3
InChI
InChIKey=PWHNTOQANLCTHN-KRWDZBQOSA-N
InChI=1S/C21H24FN5O6/c1-14(28)23-11-17-13-26(21(29)33-17)15-2-4-19(18(22)10-15)25-8-6-24(7-9-25)12-16-3-5-20(32-16)27(30)31/h2-5,10,17H,6-9,11-13H2,1H3,(H,23,28)/t17-/m0/s1
| Molecular Formula | C21H24FN5O6 |
| Molecular Weight | 461.4436 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:36:18 GMT 2025
by
admin
on
Mon Mar 31 23:36:18 GMT 2025
|
| Record UNII |
G3NB6JBL8A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
496993
Created by
admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
|
PRIMARY | |||
|
DTXSID701029733
Created by
admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
|
PRIMARY | |||
|
392659-38-0
Created by
admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
|
PRIMARY | |||
|
G3NB6JBL8A
Created by
admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Summary of MICs (micrograms per milliliter) of Ranbezolid for S. aureus strains.
Methicillin-resistant S. aureus(n 68): MIC range = 0.25-4, MIC50 = 2, MIC90 = 4
Methicillin-susceptible S. aureus(n 65): MIC range = 0.5-4, MIC50 = 2, MIC90 = 2
|
||
|
ACTIVE MOIETY |
For 260 pneumococcal and 266 staphylococcal strains, ranbezolid MICs ranged from 0.06 to 4 .MU.g/ml. The MICs for pneumococci were similar irrespective of the strains' .BETA.-lactam, macrolide, or quinolone susceptibilities, and ranbezolid MICs for coagulase-negative staphylococci were lower than those for Staphylococcus aureus. Ranbezolid was bacteriostatic against pneumococci. Ranbezolid MICs were similar to or lower than those of linezolid.
|